The relationship between immunization with active virus and development of poliomyelitis may suggest that the moderately attenuated active virus vaccine intramuscularly injected can cause non-paralytic poliomyelitis with fever symptom only, and rather high incidence of this non-paralytic form is expected. It
is not yet clear whether, in the present experiment, the adjuvant administered with vaccine had any correlation with the occurrence of paralysis. Of 7 monkeys that had developed paralysis, 3 died and 4 recovered. This recovery can be ascribed to GLC-VB 1 treatment which is intrathecally administered.
As for the evaluation of the effect of GLC-VB1 therapy another report is to be followed, 467 
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In place of the above-mentioned monkeys died during immunization with active virus vaccine, 5 monkeys received attenuated virus vaccine that allowed too stand for 3 days at room temperature added with formalin in the concentration of 0.1% in order to complete inactivation. As shown in Table 2 no symptoms indicating the onset of the disease were observed in all these 5 monkeys. Ten per cent emulsion of the spinal cord was centrifuged 3,000 rpm for 15 minutes, and the supernatant was stored in several ampules in dry ice box.
The virulence of this supernatant was as follows ; 10-2 dilution of the supernatant caused the death of the animal on 8th day after the intracerebral inoculation, and 10-3 dilution induced death of monkey on the 13th. Based on this result concerning the virulence 10-2.5 dilution was used as challenge dose. First 10% virus emulsion in frozen state was thawed and then diluted to 10-2. The immune sera collected from each monkey immunized with each strain were diluted with penicillin-streptomycin saline to twice amount. The challenge suspension and each diluted immune serum were mixed in ratio of 1:2.2, that is, the final virus dilution came to 10-2.5. After 30 minutes standing at room temperature the inoculum was intracerebrally injected to each corresponding immunized monkey. That is to say, by means of adding each specific immune serum to the challenge virus suspension, neutralization test was carried out at the same time together with challenge test on the same immunized monkeys.
The present experiment is thus designed to combine neutralization test with challenge test, which will render more reliable result. The results were tabulated in The challenge dose was decided as 10-3.7 dilution of spinal cord of infected monkey. Two tenth cc of 10-s diluted challenge virus was mixed with the same amount of immune monkey sera of each strain to be classified and 0.6 cc penicillin saline water was added each to make the total volume 1.0 cc. One half volume (0.5 cc) of this inoculum was intracerebrally inoculated to each immunized monkeys of the corresponding strain.
The test result was presented in Table 4 . 
